Literature DB >> 6233404

Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.

B F Van Duzee, J A Schaefer, J D Ball, H M Chilton, R J Cowan, C Kuni, R Trow, N E Watson.   

Abstract

To compare the efficacy of Tc-99m HMDP and Tc-99m MDP to define skeletal lesions, 28 adult patients were examined in a double-blind, randomized, crossover study. Each patient was imaged with both agents over a period of 7-14 days. Both quantitative and qualitative evaluations were performed on the resulting images. Both agents detected the same number of skeletal lesions, and the number of lesions detected was the same whether the imaging was performed 2 or 4 hr after injection. Relative uptake of the tracer in the lesion relative to normal bone was also the same for both agents. Lesions were easier to see at 4 hr after injection than at 2 hr, presumably because soft-tissue levels were lower. Retention of tracer in bone compared with soft tissue was greater, and image quality was judged to be better, with Tc-99m HMDP than with Tc-99m MDP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233404

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  Clinical differences between bone-seeking agents.

Authors:  J W Arndt; E K Pauwels; J A Camps; J Heidema
Journal:  Eur J Nucl Med       Date:  1985

2.  Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma.

Authors:  F Tenenbaum; M Schlumberger; F Bonnin; J Lumbroso; B Aubert; H Benali; C Parmentier
Journal:  Eur J Nucl Med       Date:  1993-12

3.  Clinical comparison of 99mTc-HMDP and 99mTc-MDP. A multicenter study.

Authors:  B Delaloye; A Delaloye-Bischof; R Dudczak; K Koppenhagen; F Mata; A Penafiel; F D Maul; J Pasquier
Journal:  Eur J Nucl Med       Date:  1985
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.